Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Do AGTR1 variants increase risk of low sodium during stress or low intake?

Genetic variation in AGTR1 alters RAAS signaling and shifts baseline renal sodium retention, raising susceptibility to low sodium under physiological stress or restricted intake.

PlausibleJune 19, 20267 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Variants in AGTR1 (angiotensin II type 1 receptor) can alter renin-angiotensin-aldosterone system signaling and shift renal sodium retention, affecting susceptibility to low sodium during stress or low intake.

laying out figure…
1 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that AGTR1 variants change receptor regulation and RAAS sensitivity, for example via disruption of miR-155 binding, which alters aldosterone-driven tubular sodium reabsorption. These shifts in baseline renal sodium handling can reduce the kidney's capacity to conserve sodium and thereby increase the likelihood of hyponatremia during dietary sodium restriction or physiological stress.

Verified conclusion

The renin-angiotensin-aldosterone system (RAAS) plays a pivotal role in maintaining systemic fluid and electrolyte homeostasis, primarily through the regulation of sodium retention in the renal tubules. Genetic variation in the angiotensin II type 1 receptor (AGTR1) can modify this signaling pathway, altering baseline sodium conservation.

Mechanistic pathways of AGTR1

  • Receptor Regulation: The AGTR1 gene is a critical mediator of renal tubular sodium reabsorption and adrenal aldosterone production.
  • MicroRNA Disruption: The well-characterized AGTR1 rs5186 (A1166C) polymorphism alters receptor expression by disrupting the binding site for microRNA-155 (miR-155). This disruption prevents normal post-transcriptional downregulation, leading to elevated receptor density and heightened downstream RAAS signaling.
  • Aldosterone and Sodium Reabsorption: Conversely, loss-of-function variants or receptor knockouts impair downstream aldosterone secretion and diminish the signaling required for active sodium reabsorption.

Clinical evidence and renal sodium handling

  • Animal and Human Models: In vivo models, including Agtr1a knockout mice, exhibit severe renal salt-wasting and an inability to conserve sodium under restricted intake. In humans, severe loss-of-function mutations lead to renal tubular dysgenesis and profound salt-wasting.
  • Fractional Sodium Reabsorption: Genetic variants, such as rs2131127, have been directly associated in human cohorts with changes in the fractional distal reabsorption of sodium, shifting baseline renal sodium handling.
  • Stress and Sodium Depletion: While the physiological mechanism linking impaired AGTR1 signaling to salt-wasting is robust, clinical studies of common variants like rs5186 primarily focus on hypertension and cardiovascular outcomes rather than directly quantifying the risk of clinical hyponatremia during acute dietary sodium restriction.

Bottom line

  • Genetic variations in AGTR1 alter RAAS sensitivity and downstream tubular reabsorption, shifting the baseline threshold of renal sodium retention and increasing susceptibility to low sodium levels (hyponatremia) under physiological stress or restricted sodium intake.

References

  1. Early inflammatory and metabolic changes in association with AGTR1 polymorphisms in prehypertensive subjects. — pmc.ncbi.nlm.nih.gov ↗
  2. The role of genetic polymorphisms of the Renin–Angiotensin System in renal diseases: A meta-analysis — pmc.ncbi.nlm.nih.gov ↗
  3. Functional tests to guide management in an adult with loss of function of type-1 angiotensin II receptor — link.springer.com ↗
  4. ALDOSTERONE-INDUCED VASCULAR REMODELING AND ENDOTHELIAL DYSFUNCTION REQUIRE FUNCTIONAL ANGIOTENSIN TYPE 1a RECEPTORS — ahajournals.org ↗
  5. Genomics and Pharmacogenomics of Salt-sensitive Hypertension — pmc.ncbi.nlm.nih.gov ↗
  6. Aldosterone-Regulating Receptors and Aldosterone-Driver Somatic Mutations — pmc.ncbi.nlm.nih.gov ↗
  7. Aldosterone-Regulating Receptors and Aldosterone-Driver Somatic Mutations — frontiersin.org ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→